Učitavanje...
Assessing the mechanisms of cholesteryl ester transfer protein inhibitors
Cholesteryl ester transfer protein (CETP) inhibitors are a new class of therapeutics for dyslipidemia that simultaneously improve two major cardiovascular disease (CVD) risk factors: elevated low-density lipoprotein (LDL) cholesterol and decreased high-density lipoprotein (HDL) cholesterol. However,...
Spremljeno u:
| Izdano u: | Biochim Biophys Acta Mol Cell Biol Lipids |
|---|---|
| Glavni autori: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6239860/ https://ncbi.nlm.nih.gov/pubmed/28911944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbalip.2017.09.004 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|